Autoantibody biomarkers in childhood-acquired demyelinating syndromes: Results from a national surveillance cohort

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 4, 2014, Pages 456-461

  Hacohen, Yael ^a   Absoud, Michael ^b,c   Woodhall, Mark ^a   Cummins, Carole ^c   De Goede, Christian G ^d   Hemingway, Cheryl ^e   Jardine, Philip E ^f   Kneen, Rachel ^g,h   Pike, Michael G ⁱ   Whitehouse, William P ^j   Wassmer, Evangeline ^k   Waters, Patrick ^a   Vincent, Angela ^a   Lim, Ming ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d ROYAL PRESTON HOSPITAL   (United Kingdom)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^f BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

^h ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

ⁱ JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^j UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^k BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4 ANTIBODY; AUTOANTIBODY; BIOLOGICAL MARKER; CASPR2 ANTIBODY; CONTACTIN 2 ANTIBODY; LGI1 ANTIBODY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL COMPLEX ANTIBODY;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADOLESCENT; ANTIBODY DETECTION; ARTICLE; CHILD; CHILDHOOD ACQUIRED DEMYELINATING SYNDROME; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SURVEILLANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; OPTIC NEURITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

MULTIPLE SCLEROSIS; MYELIN; NEUROIMMUNOLOGY; NMDA; PAEDIATRIC;

ADOLESCENT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; COHORT STUDIES; DEMYELINATING DISEASES; FEMALE; GREAT BRITAIN; HUMANS; MALE; NERVE TISSUE PROTEINS; NEUROIMAGING;

EID: 84895810416     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-306411     Document Type: Article

References (26)

1. Krumbholz M, Derfuss T, Hohlfeld R, et al . B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat Rev Neurol 2012;8:613-23.
2. Elliott C, Lindner M, Arthur A, et al. Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis. Brain 2012;135: 1819-33.
3. Derfuss T, Meinl E. Identifying auto antigens in demyelinating diseases: valuable clues to diagnosis and treatment? Curr Opin Neurol 2012;25:231-8.
4. Reindl M, Di Pauli F, Rostásy K, et al. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 2013;133:1655-1667.
5. Vincent A, Bien CG, Irani SR, et al. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011;10:759-72.
6. Hacohen Y, Wright S, Waters P, et al. Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry 2013;84:748-55.
7. Káradóttir R, Cavelier P, Bergersen LH, et al. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005;438:1162-6. (Pubitemid 41831686)
8. Rasband MN. Clustered K+ channel complexes in axons. Neuroscience Lett 2010;486:101-6.
9. Kruer MC, Koch TK, Bourdette DN, et al. NMDA receptor encephalitis mimicking seronegative neuromyelitis optica. Neurology 2010;74:1473-5.
10. Kalakatsios M, Hacohen Y, Siddiqui A, et al. Acute disseminated encephalomyelitis associated with positive voltage gated potassium channel complex antibody. Mult Scler Relat Disord 2013;2:147-50.
11. Absoud M, Lim MJ, Chong WK, et al. Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features. Mult Scler 2013;19:76-86.
12. O'Connor KC, McLaughlin KA, De Jager PL, et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med 2007;13:211-17.
13. Waters PJ, McKeon A, Leite MI, et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012;78:665-71.
14. Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010;133:1655-67.
15. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010;133:2734-48.
16. Hutchinson M, Waters P, McHugh J, et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 2008;71:1291-2.
17. Banwell B, Bar-Or A, Arnold DL, et al . Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol 2011;10:436-45.
18. Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006;59:566-9. (Pubitemid 43358081)
19. Matiello M, Lennon VA, Jacob A, et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008;70:2197-200.
20. J Neurol Sci2012;320:32-7.
21. Jarius S, Frederikson J, Waters P, et al. Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci 2010;298:158-62.
22. Sato DK, Nakashima I, Takahashi T, et al. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology 2013;80 (24):2210-6.
23. Boronat A, Sepúlveda M, Llufriu S, et al. Analysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis. J Neuroimmunol 2012;244:103-6.
24. Srivastava R, Aslam M, Kalluri SR, et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N Engl J Med 2012;367:115-23.
25. Paterson RW, Zandi MS, Armstrong R, et al. Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre. J Neurol Neurosurg Psychiatry 2013 Jun 11. [Epub ahead of print]
26. Brenner T, Sills GJ, Hart Y, et al. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 2013;54: 1028-35.